Qkine secures £1.6 million investment to accelerate stem cell innovation
CPI Enterprises and EverQuest Capital Partners have co-invested alongside Parkwalk Advisors and EMV Capital in a £1.6 million funding round for Cambridge-based biotechnology company Qkine, underscoring their shared commitment to backing high-potential UK life sciences businesses developing innovative technologies with global commercial impact.
Psyomics appoints US digital health leader Raj Malik to Board
Digital mental health company Psyomics has appointed experienced US healthcare executive Raj Malik to its Board as the business grows in the UK and focuses on international expansion.
Foventa Therapeutics bids for Series A cash under its new brand
Cambridge company Foventa Therapeutics, a clinical-stage ophthalmology business, is embarking on a Series A round to fund exciting technology after changing its name from Exonate.
VividQ reveals its one-of-a-kind holographic tech for bike shops
VividQ reveals its one-of-a-kind holographic tech for bike shops
Psyomics opens up new NHS procurement route for mental health tech
Psyomics opens up new NHS procurement route for mental health tech
Sustainable aviation fuel pioneer completes successful trials
Sustainable aviation fuel pioneer completes successful trials
Meet Leeds spinout ‘reinventing the injection’
Microneedle Solutions is tackling one of healthcare’s oldest challenges: replacing syringe injections with a simpler, pain-free alternative
Paragraf presents new graphene sensing platform and data acquisition system
Paragraf presents new graphene sensing platform and data acquisition system
Qureight expands with addition of second site, to accommodate rapid growth and ongoing development of chest Foundation Model
Qureight expands with addition of second site, to accommodate rapid growth and ongoing development of chest Foundation Model
Shortlists Named for 2026 VISION Award
Organizers of VISION 2026, set to take place Oct. 6-8 in Stuttgart, have unveiled their shortlist for the VISION Award. The five companies will present their innovations during a 1-h session at the Industrial Vision Days on Oct. 7.
Sifted acquires Onstage to strengthen its European startup community and events offering
European tech media company Sifted has acquired startup events platform Onstage, expanding its founder-focused offering with one of Europe’s leading Demo Day communities. The acquisition marks Sifted’s first-ever acquisition and aims to help the company support founders from the earliest stages of fundraising through to scaleup growth.
Qureight secures $20M Series B to expand AI-powered imaging platform for clinical trials
Series B funding will accelerate development of new AI disease models for lung and heart conditions, while expanding the company's imaging analytics platform.
Robot fruit-picking firm harvests growth with £14 million raise
A robotics business is set to accelerate the rollout of artificial intelligence-powered harvesting technology after securing more than £14 million support.
Dogtooth Technologies has raised funding through equity investment from 24 Haymarket, EMV Capital and ACF Investors, alongside grants from Innovate UK and a venture leasing facility from Kineo Finance.
Industry heavyweights join new advisory team at Paragraf
Cambridgeshire technology innovator Paragraf has added to its world-leading credentials by adding three international heavyweights to a new Advisory Committee. Two of them will also reinforce the Board.
Exonate appoints Olav Hellebø as Chief Executive Officer
Exonate appoints Olav Hellebø as Chief Executive Officer
Heartfelt receives Breakthrough Device Designation from FDA for heart failure monitoring tech
A groundbreaking AI-powered device developed by Heartfelt Technologies in Cambridge could be set to revolutionise how heart failure is managed in the home, after receiving Breakthrough Device Designation from the U.S. Food and Drug Administration (FDA).
Undo raises £27.6m to boost software issue diagnosis by AI agents
The funding will be used to expand go-to-market teams across the US and Europe
How ‘RNA origami’ could improve neurodegenerative disease diagnosis
University of Cambridge researchers have discovered what appears to be a transformative method of identifying mutations linked to genetic disorders.
PhoreMost announces lead oncology programme and appoints Chief Medical Officer to support clinical entry
Next-generation small molecule microtubule targeting agent, PMC-001, progressing towards Phase 1.
Cambridge startup Signaloid tapes out C0-ASIC, delivering 1000x energy savings for AI
Signaloid, a Cambridge computing platform company providing hardware and binary-translation-based acceleration of AI, robotics, aerospace, and quantitative finance workloads, has launched the tapeout and preliminary specifications documents for its C0-ASIC processor.